In This Section
Any health-related information provided on the web of the Fighting 4 the Tatas Breast Cancer Organization is made available strictly for informational purposes. In no way does this information replace the knowledge, expertise, skills or judgment of a doctor or other qualified health professional. Such information cannot be used for diagnosis or treatment purposes. You should consult a doctor or a qualified health professional in connection with any specific medical question or issue concerning your health. The hyperlinks which connect you to other Internet sites are provided solely for reference purposes and the Fighting 4 the Tatas Breast Cancer Organization assumes no responsibility as to their use or content.
Fighting Inflammatory Breast Cancer, operates as a subsidiary of Fighting 4 the Tatas Breast Cancer Incorporated.
Fighting 4 the Tatas Breast Cancer Organization is a nonprofit, tax-exempt charitable organization under Section 501(c)(3) of the Internal Revenue Code.
Donations are tax-deductible as allowed by law.Copyright © Fighting 4 the Tatas Breast Cancer Organization. All rights reserved.
WHAT IS Inflammatory breast cancer
Inflammatory Breast Cancer (IBC) is recognized as the most aggressive (fast growing) and lethal subtype of breast cancer in which cancer cells block lymph vessels in the skin of the breast and because it can spread to other organs, IBC is characterized as micro-metastasis at the time of diagnosis. Most inflammatory breast cancers are invasive ductal carcinomas, which means they developed from cells that line the milk ducts of the breast and then spread beyond the ducts.
Inflammatory Breast Cancer is among one of the rarest and most deadly forms of breast cancer. It tends to strike younger women, is aggressive and difficult to treat. Inflammatory breast cancer is considered: locally advanced breast cancer, invasive ductal carcinoma or high grade infiltrating ductal carcinoma.
It is very important to distinguish IBC from other types of breast cancer because there are major differences in its symptoms, prognosis (outlook), and treatment. It can be easily misdiagnosed or treated incorrectly, compared to more common breast cancers.
Inflammatory Breast Cancer (IBC) is entirely different from other types of breast cancer – as a result, the symptoms, prognosis and outcomes all require specific, customized attention. There are an estimated 15,000-20,000 new cases of IBC diagnosed annually, according to Dr. Massimo Cristofanilli.
Be Social Get In Touch Fighting 4 the Tatas